Moderna's mRNA-1273 vaccine helped prevent medically attended COVID-19 and related hospitalizations across multiple respiratory seasons among adults.
News-Medical.Net on MSN
Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac
Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled ...
One of the greatest achievements in the history of public health has been protection against infectious diseases by ...
New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...
Vaccines train the body's defenses to fight infections safely. Learn how vaccines work, how the immune system responds, and ...
About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn could be smaller this year as millions wrestle with conflicting advice from ...
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...
India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results